凱盛科技(600552.SH):2名董事及高管減持期屆滿 累計減持443.61萬股
格隆匯8月18日丨凱盛科技(600552.SH)公佈,截止減持計劃公告日(2020年1月23日)公司獨立董事束安俊持有公司股份10萬股,佔公司總股本的0.0131%;公司副總經理歐木蘭持有凱盛科技股份1768.46萬股,佔公司總股本的2.3151%。
自2020年2月20日至2020年8月18日,束安俊通過集中競價方式累計減持其持有的公司股份2.5萬股,佔公司總股本的0.0033%;歐木蘭通過集中競價方式累計減持其持有的公司股份441.11萬股,佔公司總股本的0.5775%。截止2020年8月18日,減持時間區間已屆滿,上述減持主體的減持計劃實施完畢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.